ESMO21

Aprea Therapeutics Stock Jumps After Eprenetapopt Combo Data Presentation At ESMO
AstraZeneca's Enhertu Posts Substantial Clinical Benefit Over Roche's Kadcyla In Breast Cancer Trials
Syros Posts Updated Data From CDK7 Inhibitor In Various Solid Tumor Settings
AstraZeneca's Enhertu Posts Substantial Clinical Benefit Over Roche's Kadcyla In Breast Cancer Trials
Syros Posts Updated Data From CDK7 Inhibitor In Various Solid Tumor Settings
Exelixis's Cabometyx Scores FDA Nod In Differentiated Thyroid Cancer; ESMO Presentation
Why Are BeyondSpring's Shares Plunging Today?

ESMO21 Recent News

Mirati Unveils Long-term Survival Data For Sitravatinib/Nivolumab Combo In Lung Cancer Patients
Mirati Posts Adagrasib Data In KRAS-Mutated Lung Cancer, FDA Filing Now On The Cards
Mirati Showcases New KRAS Drug Data In Colorectal Cancer At ESMO
Merck Backs Up Keytruda Approval In TNBC With Encouraging Overall Survival Data
Verastem Shares Are Trading Higher On Encouraging Combo Therapy Data At ESMO Presentation
Seagen, Genmab Present Tisotumab Vedotin Combo Data In Cervical Cancer
Sanofi, Regeneron, Share Competitive Libtayo Survival Data in 1L NSCLC
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA (NASDAQ: SNY) hope to expand Libtayo into a broader population with a chemo combo regimen. 
AstraZeneca-Daiichi Sankyo Share Detailed Enhertu Data In Gastric Cancer
Janssen Shares Erdafitinib Combo Therapy Data In Bladder Cancer
TCR2 Therapeutics Stock Plunges On Safety Signals From Gavo-cel Solid Tumor Trial
TCR2 Therapeutics Inc (NASDAQ: TCRR) stock dropped to a 52-week low after interim results from the ongoing Phase 1 portion of the gavo-cel Phase 1/2 trial for mesothelin-expressing solid tumors. 
Deciphera Presents New Data Across Pipeline At ESMO Congress
Corcept Therapeutics' Relacorilant Combo Therapy Shows Clinical Benefit In Ovarian Cancer
What Is Happening With Innate Pharma Stock On Friday?
Gritstone Presents Data From Individualized Neoantigen Immunotherapy In Colorectal Cancer
Junshi Biosciences, Coherus Share Toripalimab Survival Data In Esophageal Cancer
Shanghai Junshi Biosciences Co Ltd and Coherus BioSciences Inc (NASDAQ: CHRS) announced interim results from the Phase 3 JUPITER-06 trial.
Novartis' Prostate Cancer Therapy Linked To Improved Quality Of Life
Novartis AG (NYSE: NVS) is building the case for its radioligand therapy, 177Lu-PSMA-617.
Agenus' Combo Therapy Trial Shows Higher Responses In Cervical Cancer
Ayala Pharma Unveils New Interim Data From Rare Cancer Trial With AL101
NGM Bio Presents Preliminary Data From NGM120 Solid Tumor Trial
Aileron Stock Is Trading Lower After Data Presentation For Chemoprotective Agent
MacroGenics Shares Fall After MGC018 Data Fails To Impress At ESMO Presentation
MacroGenics Inc (NASDAQ: MGNX) 
Bristol Myers Touts 5-Year Kidney Cancer Data For Opdivo-Yervoy Combo Therapy
Gilead Churns Out Additional Trodelvy Data